RADIOPHARM THERANOSTICS LTD (RADX) Stock Analyst Ratings
NASDAQ:RADX - ADR
5.64 USD
+0.14 (+2.55%)
ChartMill assigns a Buy % Consensus number of 80% to RADX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.92. This target is 22.67% above the current price.
RADX was analyzed by 7 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about RADX.
In the previous month the buy percentage consensus was at a similar level.
RADX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-21 | Brookline Capital | Initiate | Buy |
| 2025-05-01 | Maxim Group | Initiate | Buy |
| 2025-03-12 | B. Riley Securities | Initiate | Buy |